NIASPAN 1000 MG EXTENDED RELEASE FILM COATED TABLETS

국가: 이스라엘

언어: 영어

출처: Ministry of Health

유효 성분:

NIACIN 1000 MG

제공처:

ABBOTT MEDICAL LABORATORIES LTD

ATC 코드:

C04AC01

약제 형태:

FILM COATED TABLETS - EXTENDED RELEASE

관리 경로:

PER OS

Manufactured by:

ABBOTT LABORATORIES , USA

치료 그룹:

NICOTINIC ACID

치료 징후:

Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hyperlipidemia. Niacin therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. 1.NIASPAN is indicated to reduce elevated TC, LDL-C, Apo B and TG levels, and to increase HDL-C in patients with primary hyperlipidemia and mixed dyslipidemia. 2.NIASPAN in combination with simvastatin or lovastatin is indicated for the treatment of primary hyperlipidemia and mixed dyslipidemia when treatment with NIASPAN, simvastatin, or lovastatin monotherapy is considered inadequate. 3.In patients with a history of myocardial infarction and hyperlipidemia, niacin is indicated to reduce the risk of recurrent nonfatal myocardial infarction. 4.In patients with a history of coronary artery disease (CAD) and hyperlipidemia, n

승인 날짜:

2012-08-01